David Weber Founder of Mosanna Therapeutics Backed bySupermoon CapitalPat Connolly LinkedIn SourcesMosanna Therapeutics Launches with $80 Million to Advance Novel Nighttime Nasal Spray for Obstructive Sleep Apnea — 2025-06 Browse all founders · Browse investors
